Literature DB >> 18059268

Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis.

Jonas Rosendahl1, Heiko Witt, Richárd Szmola, Eesh Bhatia, Béla Ozsvári, Olfert Landt, Hans-Ulrich Schulz, Thomas M Gress, Roland Pfützer, Matthias Löhr, Peter Kovacs, Matthias Blüher, Michael Stumvoll, Gourdas Choudhuri, Péter Hegyi, René H M te Morsche, Joost P H Drenth, Kaspar Truninger, Milan Macek, Gero Puhl, Ulrike Witt, Hartmut Schmidt, Carsten Büning, Johann Ockenga, Andreas Kage, David Alexander Groneberg, Renate Nickel, Thomas Berg, Bertram Wiedenmann, Hans Bödeker, Volker Keim, Joachim Mössner, Niels Teich, Miklós Sahin-Tóth.   

Abstract

Chronic pancreatitis is a persistent inflammatory disease of the pancreas, in which the digestive protease trypsin has a fundamental pathogenetic role. Here we have analyzed the gene encoding the trypsin-degrading enzyme chymotrypsin C (CTRC) in German subjects with idiopathic or hereditary chronic pancreatitis. Two alterations in this gene, p.R254W and p.K247_R254del, were significantly overrepresented in the pancreatitis group, being present in 30 of 901 (3.3%) affected individuals but only 21 of 2,804 (0.7%) controls (odds ratio (OR) = 4.6; confidence interval (CI) = 2.6-8.0; P = 1.3 x 10(-7)). A replication study identified these two variants in 10 of 348 (2.9%) individuals with alcoholic chronic pancreatitis but only 3 of 432 (0.7%) subjects with alcoholic liver disease (OR = 4.2; CI = 1.2-15.5; P = 0.02). CTRC variants were also found in 10 of 71 (14.1%) Indian subjects with tropical pancreatitis but only 1 of 84 (1.2%) healthy controls (OR = 13.6; CI = 1.7-109.2; P = 0.0028). Functional analysis of the CTRC variants showed impaired activity and/or reduced secretion. The results indicate that loss-of-function alterations in CTRC predispose to pancreatitis by diminishing its protective trypsin-degrading activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059268      PMCID: PMC2650829          DOI: 10.1038/ng.2007.44

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  17 in total

1.  Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis.

Authors:  H Witt; W Luck; M Becker; M Böhmig; A Kage; K Truninger; R W Ammann; D O'Reilly; A Kingsnorth; H U Schulz; W Halangk; V Kielstein; W T Knoefel; N Teich; V Keim
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

2.  Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis.

Authors:  H Witt; W Luck; H C Hennies; M Classen; A Kage; U Lass; O Landt; M Becker
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

3.  Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene.

Authors:  D C Whitcomb; M C Gorry; R A Preston; W Furey; M J Sossenheimer; C D Ulrich; S P Martin; L K Gates; S T Amann; P P Toskes; R Liddle; K McGrath; G Uomo; J C Post; G D Ehrlich
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

4.  Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis.

Authors:  M C Gorry; D Gabbaizedeh; W Furey; L K Gates; R A Preston; C E Aston; Y Zhang; C Ulrich; G D Ehrlich; D C Whitcomb
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

5.  A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis.

Authors:  H Witt; W Luck; M Becker
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

6.  Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis.

Authors:  G R Chandak; M M Idris; D N Reddy; S Bhaskar; P V J Sriram; L Singh
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

7.  Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations.

Authors:  Eesh Bhatia; Gourdas Choudhuri; Sadiq S Sikora; Olfert Landt; Andreas Kage; Michael Becker; Heiko Witt
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

8.  SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh.

Authors:  Alexander Schneider; Amitabh Suman; Livio Rossi; M Michael Barmada; Christoph Beglinger; Shahana Parvin; Soheli Sattar; Liaquat Ali; A K Azad Khan; Niklaus Gyr; David C Whitcomb
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

9.  Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation.

Authors:  Orsolya Király; Thomas Wartmann; Miklós Sahin-Tóth
Journal:  Gut       Date:  2007-05-24       Impact factor: 23.059

10.  Mutations of the cationic trypsinogen in hereditary pancreatitis.

Authors:  N Teich; J Mössner; V Keim
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

View more
  126 in total

Review 1.  Chymotrypsin C mutations in chronic pancreatitis.

Authors:  Jiayi Zhou; Miklós Sahin-Tóth
Journal:  J Gastroenterol Hepatol       Date:  2011-08       Impact factor: 4.029

2.  High affinity small protein inhibitors of human chymotrypsin C (CTRC) selected by phage display reveal unusual preference for P4' acidic residues.

Authors:  András Szabó; Dávid Héja; Dávid Szakács; Katalin Zboray; Katalin A Kékesi; Evette S Radisky; Miklós Sahin-Tóth; Gábor Pál
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

3.  Risk Factors for Rapid Progression From Acute Recurrent to Chronic Pancreatitis in Children: Report From INSPPIRE.

Authors:  Quin Y Liu; Maisam Abu-El-Haija; Sohail Z Husain; Bradley Barth; Melena Bellin; Douglas S Fishman; Steven D Freedman; Cheryl E Gariepy; Matthew J Giefer; Tanja Gonska; Melvin B Heyman; Ryan Himes; Tom K Lin; Asim Maqbool; Maria Mascarenhas; Brian A McFerron; Veronique D Morinville; Jaimie D Nathan; Chee Y Ooi; Emily R Perito; John F Pohl; Sue Rhee; Sarah J Schwarzenberg; Uzma Shah; David Troendle; Steven L Werlin; Michael Wilschanski; M Bridget Zimmerman; Mark E Lowe; Aliye Uc
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-08       Impact factor: 2.839

4.  Variants in pancreatic carboxypeptidase genes CPA2 and CPB1 are not associated with chronic pancreatitis.

Authors:  Eriko Nakano; Andrea Geisz; Atsushi Masamune; Tetsuya Niihori; Shin Hamada; Kiyoshi Kume; Yoichi Kakuta; Yoko Aoki; Yoichi Matsubara; Karolin Ebert; Maren Ludwig; Markus Braun; David A Groneberg; Tooru Shimosegawa; Miklós Sahin-Tóth; Heiko Witt
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-27       Impact factor: 4.052

5.  Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C.

Authors:  András Szabó; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

6.  Determinants of chymotrypsin C cleavage specificity in the calcium-binding loop of human cationic trypsinogen.

Authors:  András Szabó; Miklós Sahin-Tóth
Journal:  FEBS J       Date:  2012-10-30       Impact factor: 5.542

7.  Targeted next-generation sequencing effectively analyzed the cystic fibrosis transmembrane conductance regulator gene in pancreatitis.

Authors:  Eriko Nakano; Atsushi Masamune; Tetsuya Niihori; Kiyoshi Kume; Shin Hamada; Yoko Aoki; Yoichi Matsubara; Tooru Shimosegawa
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

8.  The guinea pig pancreas secretes a single trypsinogen isoform, which is defective in autoactivation.

Authors:  Béla Ozsvári; Péter Hegyi; Miklós Sahin-Tóth
Journal:  Pancreas       Date:  2008-08       Impact factor: 3.327

9.  Pancreatitis-associated chymotrypsinogen C (CTRC) mutant elicits endoplasmic reticulum stress in pancreatic acinar cells.

Authors:  Richárd Szmola; Miklós Sahin-Tóth
Journal:  Gut       Date:  2009-11-30       Impact factor: 23.059

Review 10.  An update on pancreatic pathophysiology (do we have to rewrite pancreatic pathophysiology?).

Authors:  Heinz F Hammer
Journal:  Wien Med Wochenschr       Date:  2014-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.